Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11120644rdf:typepubmed:Citationlld:pubmed
pubmed-article:11120644lifeskim:mentionsumls-concept:C0004611lld:lifeskim
pubmed-article:11120644lifeskim:mentionsumls-concept:C0014279lld:lifeskim
pubmed-article:11120644lifeskim:mentionsumls-concept:C0032136lld:lifeskim
pubmed-article:11120644lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:11120644lifeskim:mentionsumls-concept:C0884358lld:lifeskim
pubmed-article:11120644pubmed:issue4lld:pubmed
pubmed-article:11120644pubmed:dateCreated2001-2-13lld:pubmed
pubmed-article:11120644pubmed:abstractTextMulticopy plasmids are often chosen for the expression of recombinant genes in Escherichia coli. The high copy number is generally desired for maximum gene expression; however, the metabolic burden effects that usually result from multiple plasmid copies could prove to be detrimental for maximum productivity in certain metabolic engineering applications. In this study, low-copy mini-F plasmids were compared to high-copy pMB1-based plasmids for production of two metabolites in E. coli: polyphosphate (polyP) and lycopene derived from isopentenyl diphosphate (IPP). The stationary-phase accumulation of polyP on a per cell basis was enhanced approximately 80% when either high- or low-copy plasmids were used, from 120 micromol/g DCW without augmented polyP kinase (PPK) activity to approximately 220 micromol/g DCW. The cell density of the high-copy plasmid-containing culture at stationary phase was approximately 24% lower than the low-copy culture and 30% lower than the control culture. This difference in cell density is likely a metabolic burden effect and resulted in a lower overall product concentration for the high-copy culture (approximately 130 micromol/L culture) relative to the low-copy culture (approximately 160 micromol/L culture). When the gene for DXP (1-deoxy-D-xylulose 5-phosphate) synthase, the first enzyme in the IPP mevalonate-independent biosynthetic pathway, was expressed from the tac promoter on multicopy and low-copy plasmids, lycopene production was enhanced two- to threefold over that found in cells expressing the chromosomal copy only. Cell growth and lycopene production decreased substantially when isopropyl beta-D-thiogalactosidase (IPTG) was added to the high-copy plasmid-containing culture, suggesting that overexpression of DXP synthase was a significant metabolic burden. In the low-copy plasmid-containing culture, no differences in cell growth or lycopene production were observed with any IPTG concentrations. When dxs was placed under the control of the arabinose-inducible promoter (P(BAD)) on the low-copy plasmid, the amount of lycopene produced was proportional to the arabinose concentration and no significant changes in cell growth resulted. These results suggest that low-copy plasmids may be useful in metabolic engineering applications, particularly when one or more of the substrates used in the recombinant pathway are required for normal cellular metabolism.lld:pubmed
pubmed-article:11120644pubmed:languageenglld:pubmed
pubmed-article:11120644pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:citationSubsetIMlld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11120644pubmed:statusMEDLINElld:pubmed
pubmed-article:11120644pubmed:monthOctlld:pubmed
pubmed-article:11120644pubmed:issn1096-7176lld:pubmed
pubmed-article:11120644pubmed:authorpubmed-author:KimS WSWlld:pubmed
pubmed-article:11120644pubmed:authorpubmed-author:JonesK LKLlld:pubmed
pubmed-article:11120644pubmed:authorpubmed-author:KeaslingJ DJDlld:pubmed
pubmed-article:11120644pubmed:issnTypePrintlld:pubmed
pubmed-article:11120644pubmed:volume2lld:pubmed
pubmed-article:11120644pubmed:ownerNLMlld:pubmed
pubmed-article:11120644pubmed:authorsCompleteYlld:pubmed
pubmed-article:11120644pubmed:pagination328-38lld:pubmed
pubmed-article:11120644pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:meshHeadingpubmed-meshheading:11120644...lld:pubmed
pubmed-article:11120644pubmed:year2000lld:pubmed
pubmed-article:11120644pubmed:articleTitleLow-copy plasmids can perform as well as or better than high-copy plasmids for metabolic engineering of bacteria.lld:pubmed
pubmed-article:11120644pubmed:affiliationDepartment of Chemical Engineering, University of California, Berkeley, California 94720-1462, USA.lld:pubmed
pubmed-article:11120644pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:945060entrezgene:pubmedpubmed-article:11120644lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11120644lld:pubmed